Cargando…

Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review

BACKGROUND: Clinical Practice Guidelines (CPGs) should follow an adequate methodology using an evidence-based approach in order to provide reliable recommendations. However, little is known regarding the quality of CPGs for Depression, which precludes its adequate use by stakeholders and mental heal...

Descripción completa

Detalles Bibliográficos
Autores principales: Zafra-Tanaka, Jessica Hanae, Goicochea-Lugo, Sergio, Villarreal-Zegarra, David, Taype-Rondan, Alvaro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381686/
https://www.ncbi.nlm.nih.gov/pubmed/30786870
http://dx.doi.org/10.1186/s12888-019-2057-z
_version_ 1783396550395822080
author Zafra-Tanaka, Jessica Hanae
Goicochea-Lugo, Sergio
Villarreal-Zegarra, David
Taype-Rondan, Alvaro
author_facet Zafra-Tanaka, Jessica Hanae
Goicochea-Lugo, Sergio
Villarreal-Zegarra, David
Taype-Rondan, Alvaro
author_sort Zafra-Tanaka, Jessica Hanae
collection PubMed
description BACKGROUND: Clinical Practice Guidelines (CPGs) should follow an adequate methodology using an evidence-based approach in order to provide reliable recommendations. However, little is known regarding the quality of CPGs for Depression, which precludes its adequate use by stakeholders and mental health professionals. Thus, the aim of this study was to conduct a scoping review to describe the characteristics and quality of CPGs for Depression in adults. METHODS: We searched CPGs for Depression in adults in eighteen databases. We included those that were published in English or Spanish between January 2014 and May 2018 and were based on systematic reviews of the evidence. Two independent authors extracted the characteristics, type and number of recommendations, and quality (using the Appraisal of Guidelines for Research and Evaluation-II [AGREE-II]) of each included CPG. RESULTS: We included eleven CPGs, of which 9/11 did not include the participation of patients in the development of the CPG, 4/11 CPGs had a score ≥ 70% in the overall evaluation of AGREE-II, and 3/11 CPGs had a score ≥ 70% in its third domain (rigor of development). In addition, only 5/11 CPGs shared their search strategy, while only 4/11 listed the selected studies they used to reach recommendations, and 7/11 CPGs did not clearly state which methodology they used to translate evidence into a recommendation. CONCLUSIONS: Most of evaluated CPGs did not take into account the patient’s viewpoints, achieved a low score in the rigor of development domain, and did not clearly state the process used to reach the recommendations. Stakeholders, CPCGs developers, and CPGs users should take this into account when choosing CPGs, and interpreting and putting into practice their issued recommendations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12888-019-2057-z) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6381686
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-63816862019-03-01 Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review Zafra-Tanaka, Jessica Hanae Goicochea-Lugo, Sergio Villarreal-Zegarra, David Taype-Rondan, Alvaro BMC Psychiatry Research Article BACKGROUND: Clinical Practice Guidelines (CPGs) should follow an adequate methodology using an evidence-based approach in order to provide reliable recommendations. However, little is known regarding the quality of CPGs for Depression, which precludes its adequate use by stakeholders and mental health professionals. Thus, the aim of this study was to conduct a scoping review to describe the characteristics and quality of CPGs for Depression in adults. METHODS: We searched CPGs for Depression in adults in eighteen databases. We included those that were published in English or Spanish between January 2014 and May 2018 and were based on systematic reviews of the evidence. Two independent authors extracted the characteristics, type and number of recommendations, and quality (using the Appraisal of Guidelines for Research and Evaluation-II [AGREE-II]) of each included CPG. RESULTS: We included eleven CPGs, of which 9/11 did not include the participation of patients in the development of the CPG, 4/11 CPGs had a score ≥ 70% in the overall evaluation of AGREE-II, and 3/11 CPGs had a score ≥ 70% in its third domain (rigor of development). In addition, only 5/11 CPGs shared their search strategy, while only 4/11 listed the selected studies they used to reach recommendations, and 7/11 CPGs did not clearly state which methodology they used to translate evidence into a recommendation. CONCLUSIONS: Most of evaluated CPGs did not take into account the patient’s viewpoints, achieved a low score in the rigor of development domain, and did not clearly state the process used to reach the recommendations. Stakeholders, CPCGs developers, and CPGs users should take this into account when choosing CPGs, and interpreting and putting into practice their issued recommendations. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12888-019-2057-z) contains supplementary material, which is available to authorized users. BioMed Central 2019-02-20 /pmc/articles/PMC6381686/ /pubmed/30786870 http://dx.doi.org/10.1186/s12888-019-2057-z Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zafra-Tanaka, Jessica Hanae
Goicochea-Lugo, Sergio
Villarreal-Zegarra, David
Taype-Rondan, Alvaro
Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review
title Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review
title_full Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review
title_fullStr Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review
title_full_unstemmed Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review
title_short Characteristics and quality of clinical practice guidelines for depression in adults: a scoping review
title_sort characteristics and quality of clinical practice guidelines for depression in adults: a scoping review
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6381686/
https://www.ncbi.nlm.nih.gov/pubmed/30786870
http://dx.doi.org/10.1186/s12888-019-2057-z
work_keys_str_mv AT zafratanakajessicahanae characteristicsandqualityofclinicalpracticeguidelinesfordepressioninadultsascopingreview
AT goicochealugosergio characteristicsandqualityofclinicalpracticeguidelinesfordepressioninadultsascopingreview
AT villarrealzegarradavid characteristicsandqualityofclinicalpracticeguidelinesfordepressioninadultsascopingreview
AT tayperondanalvaro characteristicsandqualityofclinicalpracticeguidelinesfordepressioninadultsascopingreview